Last $2.37 USD
Change Today -0.01 / -0.42%
Volume 333.5K
PTIE On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

pain therapeutics inc (PTIE) Snapshot

Open
$2.36
Previous Close
$2.38
Day High
$2.42
Day Low
$2.36
52 Week High
05/9/13 - $5.57
52 Week Low
11/9/12 - $2.06
Market Cap
107.4M
Average Volume 10 Days
330.7K
EPS TTM
$-0.08
Shares Outstanding
45.3M
EX-Date
12/13/12
P/E TM
--
Dividend
--
Dividend Yield
31.65%
Current Stock Chart for PAIN THERAPEUTICS INC (PTIE)

Related News

No related news articles were found.

pain therapeutics inc (PTIE) Related Businessweek News

No Related Businessweek News Found

pain therapeutics inc (PTIE) Details

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs. Its lead drug candidate is REMOXY (oxycodone) Extended-Release Capsules CII, an investigational drug with a controlled release formulation of oxycodone for patients with moderate-to-severe chronic pain. The company’s other product candidates comprise hydromorphone, hydrocodone, and oxymorphone, which are abuse-resistant opioid product candidates. Pain Therapeutics, Inc. has strategic alliance with Pfizer, Inc. to develop and commercialize REMOXY and other abuse-resistant opioid painkillers. The company was founded in 1998 and is based in Austin, Texas.

8 Employees
Last Reported Date: 02/8/13
Founded in 1998

pain therapeutics inc (PTIE) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $1.2M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $425.0K
Chief Operating & Medical Officer and Directo...
Total Annual Compensation: $550.0K
Chief Scientific Officer
Total Annual Compensation: $400.0K
Compensation as of Fiscal Year 2012.

pain therapeutics inc (PTIE) Key Developments

Pain Therapeutics Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-06-2013 02:00 PM

Pain Therapeutics Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-06-2013 02:00 PM. Venue: Grand Hyatt Hotel, 109 East 42nd Street at Grand Central, New York, New York, United States. Speakers: Peter S. Roddy, Chief Financial Officer, Principal Accounting Officer and Vice President.

Pain Therapeutics Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013

Pain Therapeutics Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the period, the company’s total revenue was $1,958,000 against $2,973,000 a year ago. Operating loss was $443,000 against $148,000 a year ago. Net loss was $408,000 or $0.01 basic and diluted per share against income of $30,000 a year ago.

Pain Therapeutics Inc., Annual General Meeting, May 16, 2013

Pain Therapeutics Inc., Annual General Meeting, May 16, 2013., at 10:00 Central Standard Time. Location: 7801 N Capital of Texas Highway. Agenda: To elect Nadav Friedmann, Ph.D., M.D. and Michael J. O’Donnell as Class I Directors to serve for three-year terms and until their successors are duly elected and qualified; to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2013; to approve, by a non-binding advisory vote, the 2012 executive compensation for the company’s executive officers; and to transact such other business as may properly be brought before the meeting and any adjournments thereof.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTIE:US $2.37 USD -0.01

PTIE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hi-Tech Pharmacal Co Inc $33.86 USD -0.05
Horizon Pharma Inc $2.37 USD +0.05
Neurocrine Biosciences Inc $12.88 USD +0.18
Pozen Inc $4.96 USD -0.16
Synta Pharmaceuticals Corp $3.88 USD -0.12
View Industry Companies
 

Industry Analysis

PTIE

Industry Average

Valuation PTIE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.8x
Price/Book 8.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAIN THERAPEUTICS INC, please visit www.paintrials.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.